Premium
P4‐164: ALZHEIMER'S DISEASE PATIENT AND CAREGIVER ENGAGEMENT INITIATIVE (AD PACE): DETERMINING WHAT MATTERS MOST TO ALZHEIMER'S PATIENTS AND CAREGIVERS TO INFORM THE DEVELOPMENT OF NEW THERAPIES, PAYMENT AND COVERAGE DETERMINATIONS, AND DELIVERY OF CARE SERVICES
Author(s) -
Martin Allison D.,
Vradenburg George,
Comer Meryl,
Callahan Leigh F.,
Winfield John,
Rubino Ivana,
Hellsvik Karin,
Krasa Holly B.,
Pratt Gregg A.,
Kremer Ian N.,
Wieberg Dan,
Frangiosa Terry,
Lappin Debra,
Hauber A Brett
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.2569
Subject(s) - pace , reimbursement , medicine , disease , payment , psychology , public relations , business , political science , health care , geodesy , finance , pathology , law , geography
during the 36 months preceding and the 12 months following the first AD diagnosis for the AD cohort or a matched date in the control cohort. Mean costs among matched AD and control cohorts were compared via bivariate analyses (a1⁄40.05). Results: A total of 76,102 AD patients and matched control patients were included in the analysis. The matched cohorts were 62% female and had a mean age of 83 years. In the first 12 months following diagnosis, mean annual total costs among the AD cohort were $28,048, which was nearly double the costs among controls ($15,166; p<0.001). During the 36-month baseline period, mean per-person annual total costs were also significantly higher among the AD cohort compared to the control cohort ($16,691 vs. $12,819; p<0.001). Baseline emergency department costs and inpatient admission costs showed the greatest relative difference with AD patients incurring costs 2.04, and 1.44 times higher than controls, respectively. Conclusions: These results demonstrate that AD patients incur significantly higher costs, particularly in the first year after diagnosis, but also over three years prior to diagnosis compared to similarly aged enrollees without AD. Further characterizing the healthcare needs during this time preceding diagnosis may help inform early disease management strategies.